Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

IGC Pharma, Inc. Common Stock (NY:IGC)

0.2964 -0.0027 (-0.90%)
Official Closing Price Updated: 8:00 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
45 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients
From India Globalization Capital, Inc.
Via Business Wire
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
From India Globalization Capital, Inc.
Via Business Wire
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
From India Globalization Capital, Inc.
Via Business Wire
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
From India Globalization Capital, Inc.
Via Business Wire
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Galectin Therapeutics Inc. (NASDAQ: GALT) rose 37.6% to $2.98 in pre-market trading after the company said a paper published in the peer-reviewed Journal for... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.